Skip to main content

Animations

MJFF Publications

6291 - 6300 of 6440 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2012
  • 2010
  • 2023
  • 2020
  • 2020
  • 2018
  • 2024
  • 2026
  • Summary Details
    OPEN
    Title: Frontostriatal and limbic contributions to cognitive decline in Parkinson's disease
    Journal Name: Journal of Neuroimaging
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jon.13045
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Fine mapping of the HLA locus in Parkinson’s disease in Europeans
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00231-5
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.020
    Citation Count: 150
  • Summary Details
    OPEN
    Title: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009
    Citation Count: 215
  • Summary Details
    OPEN
    Title: Whole proteome copy number dataset in primary mouse cortical neurons
    Journal Name: Data in Brief
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.dib.2023.109336
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-020-01004-6
    Citation Count: 23
  • Summary Details
    OPEN
    Title: The effect of LRRK2 loss-of-function variants in humans
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-020-0893-5
    Citation Count: 109
  • Summary Details
    OPEN
    Title: Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.12.066
    Citation Count: 705
  • Summary Details
    OPEN
    Title: Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2024.05.017
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Biochemical signatures of skin α-synuclein in synucleinopathies revealed by RT-QuIC assay end-product analysis
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-025-02973-5
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.